Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It began promoting MERREM I.V. (meropenem for injection) in the U.S. in July 2008. MERREM is an established spectrum antibiotic developed by AstraZeneca. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials; CONSERV-1 and CONSERV-2 for the reduction of blood loss during cardiac surgery; and two Phase 1 programs that address unmet medical needs, one in CDAD (Clostridium difficile-associated diarrhea) and the other in multi-drug resistant (MDR) Gram-negative infections. In addition, the company, in collaboration with Alnylam Pharmaceuticals, Inc., has a pre-IND and a Phase 2 program underway in novel treatments for respiratory syncytial virus infections using Alnylam's RNA-interference technology. Cubist was founded in 1992 and is headquartered in Lexington, Massachusetts.
SaaS Adoption
SaaS Adoption indicates the level of adoption by this company of software as a service services.
Cloud Adoption
Cloud Adoption indicates the level of adoption by this company of cloud services.
IT Footprint
IT Footprint gives a relative indication of how much IT services this company consumes.
IT Spend
IT Spend shows roughly how much this client spends on IT per year in USD.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Cubist Pharmaceuticals uses 5 different technologies from 120 different vendors. They have above average use of several technologies including Java, Oracle Supply Chain Management and Perl.
Cubist Pharmaceuticals uses products from 72 different product categories. They are particularly heavy users of products in Database Management System, Operating Systems, and Unified Communications.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Technology | Category | Vendor | Usage |
---|---|---|---|
Java | Programming Languages | Oracle | |
Oracle Supply Chain Management | Supply Chain Management (SCM) | Oracle | |
Perl | Programming Languages | Perl | |
Python | Programming Languages | Python Software Foundation | |
Oracle E-Business | Enterprise Applications | Oracle |
What other companies use Java?
Who are the biggest users of Supply Chain Management (SCM)?
What countries, industries, and company sizes are most likely to use Perl?